Blocking PKMYT1 activity was effective in eradication of CCNE1-amplified ovarian cancer cells, but not cell lines without amplification through preventing completion of DNA synthesis and increasing the rates of premature mitotic entry [44]. Here, CCNE1 is linked to ovarian carcinoma.